Literature DB >> 28251094

Development of a new choroidal metastasis in resistance to crizotinib therapy in anaplastic lymphoma kinase-rearranged non-small cell lung cancer.

Zhi-Hua Cui1, Yan Zhang1, Ling-Ling Liang1, Zhao-Hui Li2, Inna Abramova3, Qian Hao1.   

Abstract

Entities:  

Year:  2017        PMID： 28251094      PMCID： PMC5313558          DOI： 10.18240/ijo.2017.02.21

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN： 2222-3959            Impact factor:   1.779


× No keyword cloud information.
  23 in total

1.  Carcinoma lung presenting with choroidal metastasis as initial presentation: a rarity.

Authors:  Tapesh Bhattacharyya; Rakesh Kapoor; Amit Bahl; Budhi Singh Yadav; Usha Singh; Kusum Joshi; Swapnil Rane; S C Sharma
Journal:  J Cancer Res Ther       Date:  2013 Jul-Sep       Impact factor: 1.805

Review 2.  Molecular targeted therapy in the treatment of advanced stage non-small cell lung cancer (NSCLC).

Authors:  Nesaretnam Barr Kumarakulasinghe; Nico van Zanwijk; Ross A Soo
Journal:  Respirology       Date:  2015-02-17       Impact factor: 6.424

Review 3.  ALK and crizotinib: after the honeymoon…what else? Resistance mechanisms and new therapies to overcome it.

Authors:  Christian Rolfo; Francesco Passiglia; Marta Castiglia; Luis E Raez; Paul Germonpre; Ignacio Gil-Bazo; Karen Zwaenepoel; Annemieke De Wilde; Giuseppe Bronte; Antonio Russo; Jan P Van Meerbeeck; Paul Van Schil; Patrick Pauwels
Journal:  Transl Lung Cancer Res       Date:  2014-08

Review 4.  Choroidal metastasis as a presenting manifestation of lung cancer: a report of 3 cases and systematic review of the literature.

Authors:  Navneet Singh; Pandurang Kulkarni; Ashutosh N Aggarwal; Bhagwant Rai Mittal; Nalini Gupta; Digambar Behera; Amod Gupta
Journal:  Medicine (Baltimore)       Date:  2012-07       Impact factor: 1.889

Review 5.  Uveal metastatic disease: current and new treatment options (review).

Authors:  Gian Paolo Giuliari; Ama Sadaka
Journal:  Oncol Rep       Date:  2011-11-28       Impact factor: 3.906

Review 6.  Management of choroidal metastases.

Authors:  P Jardel; W Sauerwein; T Olivier; E Bensoussan; C Maschi; F Lanza; C Mosci; L Gastaud; G Angellier; P-Y Marcy; J Herault; J-P Caujolle; R Dendale; J Thariat
Journal:  Cancer Treat Rev       Date:  2014-10-05       Impact factor: 12.111

7.  Choroidal metastasis response to crizotinib in a ROS1-rearranged NSCLC patient.

Authors:  Stephanie Lu; Michele C Azada; Sai-Hong Ignatius Ou
Journal:  Lung Cancer       Date:  2014-12-19       Impact factor: 5.705

8.  Choroidal mass as an initial presentation of lung cancer.

Authors:  Tulay Simsek; Yasemin Ozdamar; Nilufer Berker
Journal:  Med Oncol       Date:  2008-03-11       Impact factor: 3.064

9.  Uveal metastasis from lung cancer: clinical features, treatment, and outcome in 194 patients.

Authors:  Sanket U Shah; Arman Mashayekhi; Carol L Shields; Harpreet S Walia; G Baker Hubbard; Junjun Zhang; Jerry A Shields
Journal:  Ophthalmology       Date:  2013-08-26       Impact factor: 12.079

Review 10.  The anaplastic lymphoma kinase as an oncogene in solid tumors.

Authors:  Claudia Voena; Silvia Peola; Roberto Chiarle
Journal:  Front Biosci (Schol Ed)       Date:  2015-06-01
View more
  1 in total

Review 1.  Metastasis manners and the underlying mechanisms of ALK and ROS1 rearrangement lung cancer and current possible therapeutic strategies.

Authors:  Xing Chang; Zi Liu; Shuai Man; Annie Roys; Zengqiang Li; Daiying Zuo; Yingliang Wu
Journal:  RSC Adv       Date:  2019-06-07       Impact factor: 4.036
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.